Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

Antonella Vitale; Anna Guarini; Cristina Ariola; Giovanna Meloni; Omar Perbellini; Michele Pizzuti; Cinzia De Gregoris; Vincenzo Mettivier; Alessandro Pastorini; Giovanni Pizzolo

doi:10.3324/haematol.10385

Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

Identifier:nobleid.org/w1/20260515/AF33825D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF33825D.svg?ark=w1%2F20260515%2FAF33825D)](https://nobleid.org/work/w1/20260515/AF33825D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

Identifier:nobleid.org/w1/20260515/AF33825D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF33825D.svg?ark=w1%2F20260515%2FAF33825D)](https://nobleid.org/work/w1/20260515/AF33825D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work